Nifty
Sensex
:
:
14371.90
48878.54
-218.45 (-1.50%)
-746.22 (-1.50%)

Pharmaceuticals & Drugs

Rating :
44/99  (View)

BSE: 532660 | NSE: VIVIMEDLAB

16.65
-0.30 (-1.77%)
22-Jan-2021 | 4:00PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  16.65
  •  17.10
  •  15.90
  •  16.95
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  217009
  •  36.13
  •  23.35
  •  6.20

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 139.71
  • N/A
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,032.74
  • N/A
  • 0.18

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 32.79%
  • 5.95%
  • 40.31%
  • FII
  • DII
  • Others
  • 3.1%
  • 0.12%
  • 17.73%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.79
  • -4.68
  • -3.70

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -22.74
  • -50.60
  • -49.55

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 4.62
  • 3.72
  • 2.64

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.80
  • 0.69
  • 0.30

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.98
  • 9.35
  • 11.62

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 20
Sep 19
Var%
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Net Sales
221.74
281.07
-21.11%
322.79
344.21
-6.22%
235.82
348.08
-32.25%
197.70
243.93
-18.95%
Expenses
206.34
284.53
-27.48%
276.21
303.11
-8.87%
256.48
326.69
-21.49%
206.57
207.18
-0.29%
EBITDA
15.41
-3.46
-
46.58
41.10
13.33%
-20.66
21.39
-
-8.87
36.74
-
EBIDTM
6.95%
-1.23%
14.43%
11.94%
-8.76%
6.14%
-4.49%
15.06%
Other Income
1.89
2.48
-23.79%
1.81
1.27
42.52%
2.42
6.10
-60.33%
2.09
6.31
-66.88%
Interest
13.65
15.59
-12.44%
14.88
12.11
22.87%
14.71
12.83
14.65%
16.48
17.56
-6.15%
Depreciation
17.56
16.90
3.91%
17.29
16.95
2.01%
17.48
16.05
8.91%
15.62
15.29
2.16%
PBT
-13.91
-33.47
-
16.22
13.31
21.86%
-50.44
-1.40
-
-38.88
10.21
-
Tax
-0.29
-7.12
-
3.38
3.16
6.96%
10.40
-1.41
-
-6.80
-0.63
-
PAT
-13.62
-26.35
-
12.84
10.15
26.50%
-60.84
0.02
-
-32.07
10.84
-
PATM
-6.14%
-9.38%
3.98%
2.95%
-25.80%
0.00%
-16.22%
4.44%
EPS
-1.64
-3.18
-
1.55
1.22
27.05%
-7.34
0.00
-
-3.87
1.31
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
978.05
1,058.80
1,315.17
1,185.66
1,461.91
1,345.63
1,380.10
1,350.83
1,108.80
668.31
416.00
Net Sales Growth
-19.65%
-19.49%
10.92%
-18.90%
8.64%
-2.50%
2.17%
21.83%
65.91%
60.65%
 
Cost Of Goods Sold
386.16
462.55
518.40
479.67
536.28
624.05
646.23
656.33
513.27
337.39
236.97
Gross Profit
591.89
596.24
796.77
705.99
925.63
721.58
733.88
694.51
595.52
330.93
179.03
GP Margin
60.52%
56.31%
60.58%
59.54%
63.32%
53.62%
53.18%
51.41%
53.71%
49.52%
43.04%
Total Expenditure
945.60
1,052.24
1,146.24
984.93
1,057.46
1,122.68
1,158.21
1,166.29
928.00
538.02
329.44
Power & Fuel Cost
-
42.46
42.77
34.73
34.78
38.26
46.70
51.39
44.06
22.33
11.08
% Of Sales
-
4.01%
3.25%
2.93%
2.38%
2.84%
3.38%
3.80%
3.97%
3.34%
2.66%
Employee Cost
-
233.36
241.76
197.78
189.98
176.94
184.43
162.66
50.33
32.19
19.97
% Of Sales
-
22.04%
18.38%
16.68%
13.00%
13.15%
13.36%
12.04%
4.54%
4.82%
4.80%
Manufacturing Exp.
-
196.36
217.39
176.69
175.06
167.31
179.26
182.37
230.50
91.61
32.06
% Of Sales
-
18.55%
16.53%
14.90%
11.97%
12.43%
12.99%
13.50%
20.79%
13.71%
7.71%
General & Admin Exp.
-
96.13
111.52
78.75
93.93
95.26
76.30
86.64
69.34
31.42
15.96
% Of Sales
-
9.08%
8.48%
6.64%
6.43%
7.08%
5.53%
6.41%
6.25%
4.70%
3.84%
Selling & Distn. Exp.
-
13.82
14.41
16.66
15.39
20.86
25.29
26.91
20.50
23.09
11.26
% Of Sales
-
1.31%
1.10%
1.41%
1.05%
1.55%
1.83%
1.99%
1.85%
3.45%
2.71%
Miscellaneous Exp.
-
7.56
0.00
0.65
12.03
0.00
0.00
0.00
0.00
0.00
11.26
% Of Sales
-
0.71%
0%
0.05%
0.82%
0%
0%
0%
0%
0%
0.51%
EBITDA
32.46
6.56
168.93
200.73
404.45
222.95
221.89
184.54
180.80
130.29
86.56
EBITDA Margin
3.32%
0.62%
12.84%
16.93%
27.67%
16.57%
16.08%
13.66%
16.31%
19.50%
20.81%
Other Income
8.21
11.95
33.97
23.76
8.09
23.63
8.02
35.90
26.33
2.68
1.00
Interest
59.72
61.03
70.06
82.35
67.79
85.26
86.20
67.46
50.44
28.37
22.10
Depreciation
67.95
66.95
66.79
56.42
58.28
61.39
66.18
66.12
58.81
26.79
10.20
PBT
-87.01
-109.47
66.05
85.71
286.48
99.93
77.54
86.86
97.88
77.82
55.26
Tax
6.69
-0.36
8.68
9.62
72.50
16.26
5.49
20.47
14.29
14.68
6.43
Tax Rate
-7.69%
0.33%
13.14%
11.22%
25.31%
16.27%
7.08%
23.57%
14.60%
18.86%
11.64%
PAT
-93.69
-109.11
57.37
77.94
213.97
83.67
72.05
66.39
83.58
63.14
48.83
PAT before Minority Interest
-93.69
-109.11
57.37
76.09
213.97
83.67
72.05
66.39
83.58
63.14
48.83
Minority Interest
0.00
0.00
0.00
1.85
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-9.58%
-10.31%
4.36%
6.57%
14.64%
6.22%
5.22%
4.91%
7.54%
9.45%
11.74%
PAT Growth
0.00%
-290.19%
-26.39%
-63.57%
155.73%
16.13%
8.53%
-20.57%
32.37%
29.31%
 
Unadjusted EPS
-11.30
-13.16
6.92
9.40
25.81
10.09
8.69
8.01
10.08
7.62
5.89

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
834.59
943.79
1,226.40
734.21
585.15
559.24
560.36
509.14
474.79
196.71
Share Capital
341.80
341.73
341.73
16.20
80.15
80.15
80.15
80.01
144.88
10.16
Total Reserves
492.79
602.07
884.67
718.01
505.00
479.09
477.84
426.77
327.54
177.68
Non-Current Liabilities
590.94
489.65
356.86
503.86
561.11
538.36
532.58
449.68
360.72
148.25
Secured Loans
414.68
369.08
275.90
396.25
206.75
436.44
378.81
255.19
258.03
131.90
Unsecured Loans
55.71
55.72
49.30
57.07
50.52
46.94
40.92
41.73
53.35
0.00
Long Term Provisions
5.14
9.21
7.03
2.19
3.57
3.17
5.16
1.47
1.06
1.69
Current Liabilities
770.36
888.93
790.23
817.39
897.41
800.86
744.42
610.73
463.69
242.44
Trade Payables
226.50
294.42
201.99
178.59
166.74
188.71
190.49
166.28
156.86
44.06
Other Current Liabilities
101.78
227.11
147.64
179.92
285.85
176.38
138.78
116.10
40.79
4.68
Short Term Borrowings
418.51
332.30
385.16
381.47
407.76
389.38
375.43
301.13
232.82
175.08
Short Term Provisions
23.56
35.10
55.43
77.41
37.06
46.39
39.71
27.22
33.21
18.61
Total Liabilities
2,195.89
2,322.37
2,385.77
2,055.46
2,043.67
1,898.46
1,837.36
1,569.55
1,299.20
587.40
Net Block
1,045.12
964.92
1,035.36
878.90
814.17
813.47
807.92
709.04
595.35
264.29
Gross Block
1,271.07
1,156.58
1,128.64
915.77
1,663.33
1,599.11
1,526.04
1,329.52
1,167.48
812.71
Accumulated Depreciation
225.95
191.65
93.29
36.87
849.16
785.64
718.12
620.49
572.13
548.42
Non Current Assets
1,220.61
1,091.77
1,103.83
961.04
911.03
906.45
846.28
736.20
604.41
266.01
Capital Work in Progress
89.28
122.31
65.27
76.13
94.17
90.28
38.12
26.92
8.37
1.73
Non Current Investment
85.71
2.51
2.70
2.71
2.69
2.70
0.24
0.24
0.70
0.00
Long Term Loans & Adv.
0.00
1.52
0.00
2.81
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
0.50
0.50
0.50
0.50
0.00
0.00
0.00
0.00
0.00
0.00
Current Assets
975.28
1,230.61
1,281.94
1,094.42
1,132.60
991.96
970.90
815.08
647.14
314.68
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
501.91
563.69
540.17
483.97
490.80
431.43
426.66
340.26
247.88
84.47
Sundry Debtors
249.07
356.11
275.43
200.14
326.24
329.58
347.83
308.23
221.61
127.56
Cash & Bank
50.49
95.31
99.03
55.47
30.96
26.67
34.57
23.96
36.34
11.10
Other Current Assets
173.82
30.75
29.59
22.53
284.61
204.28
161.84
142.64
141.32
91.55
Short Term Loans & Adv.
140.96
184.76
337.73
332.31
272.88
185.21
139.50
119.82
141.09
89.45
Net Current Assets
204.92
341.68
491.71
277.03
235.19
191.10
226.47
204.35
183.45
72.25
Total Assets
2,195.89
2,322.38
2,385.77
2,055.46
2,043.67
1,898.45
1,837.36
1,569.55
1,299.21
587.39

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
79.56
422.14
21.42
57.96
154.12
140.48
-117.65
90.11
45.17
23.89
PBT
-109.47
66.05
85.71
286.48
99.93
77.54
86.86
97.88
77.81
55.26
Adjustment
125.89
134.05
135.90
124.15
101.94
111.32
101.31
80.43
55.16
32.30
Changes in Working Capital
83.08
237.03
-158.14
-315.94
-47.75
-48.38
-305.83
-94.13
-87.81
-63.67
Cash after chg. in Working capital
99.50
437.13
63.48
94.69
154.12
140.48
-117.65
84.18
45.17
23.89
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-19.94
-14.99
-42.06
-36.73
0.00
0.00
0.00
5.93
0.00
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-196.01
-88.87
-163.53
-68.49
-190.42
-106.71
-291.11
-169.59
-424.15
-72.39
Net Fixed Assets
9.10
-15.53
38.52
-25.51
-6.97
-49.04
-16.56
-128.68
-148.52
-26.78
Net Investments
0.03
64.34
-64.27
142.45
0.00
-2.50
-132.00
-8.38
-83.77
0.09
Others
-205.14
-137.68
-137.78
-185.43
-183.45
-55.17
-142.55
-32.53
-191.86
-45.70
Cash from Financing Activity
72.44
-337.80
185.66
35.05
40.59
-41.67
419.37
67.10
404.22
53.98
Net Cash Inflow / Outflow
-44.02
-4.53
43.56
24.51
4.29
-7.90
10.62
-12.38
25.24
5.47
Opening Cash & Equivalents
94.50
99.03
55.47
30.96
26.67
34.57
23.96
36.34
11.10
5.62
Closing Cash & Equivalent
50.49
94.50
99.03
55.47
30.96
26.67
34.57
23.96
36.34
11.10

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
56.85
70.35
104.60
85.93
64.20
61.00
58.36
52.74
42.03
35.45
ROA
-4.83%
2.44%
3.43%
10.44%
4.25%
3.86%
3.90%
5.83%
6.69%
9.36%
ROE
-20.75%
7.95%
9.76%
35.18%
16.50%
14.90%
14.81%
23.34%
26.70%
31.18%
ROCE
-2.69%
7.03%
9.04%
21.86%
11.93%
10.91%
11.93%
13.83%
14.29%
17.80%
Fixed Asset Turnover
0.87
1.15
1.16
1.13
0.82
0.88
0.95
0.89
0.67
0.76
Receivable days
104.31
87.64
73.20
65.71
88.94
89.58
88.63
87.21
95.35
97.13
Inventory Days
183.67
153.18
157.64
121.69
125.08
113.47
103.61
96.80
90.76
71.87
Payable days
92.05
79.66
70.90
60.76
60.42
57.00
57.11
62.91
65.22
47.96
Cash Conversion Cycle
195.94
161.15
159.93
126.64
153.61
146.05
135.14
121.10
120.89
121.04
Total Debt/Equity
1.18
1.05
0.69
1.45
1.63
1.81
1.66
1.36
1.33
1.70
Interest Cover
-0.79
1.94
2.04
5.23
2.17
1.90
2.29
2.94
3.74
3.50

Annual Reports:


News Update


  • Vivimed Labs gets nod for 3 ophthalmic products, 3 oral liquid suspension products
    23rd Nov 2020, 11:46 AM

    The company has received approvals for 3 ophthalmic products from its state of the art sterile Ophthalmic facility

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.